Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 90,701–90,710 of 90,710 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00052130	Vaccine Therapy for Patients With Stage III Melanoma	unknown	Phase 3	1,118	CancerVax CorporationINDUSTRY	13	Jun 24, 2005	clinicaltrials
NCT00052156	Vaccine Therapy for Patients With Stage IV Melanoma	unknown	Phase 3	670	CancerVax CorporationINDUSTRY	13	Jun 24, 2005	clinicaltrials
NCT00054951